Global Sustained Release Drug Delivery Systems Market Research Report 2023

Publication ID:

PB509235838

Publication Date:

September 28, 2023

Pages:

120

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Sustained Release Drug Delivery System (SRDDS) is designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects.
The global Sustained Release Drug Delivery Systems market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sustained Release Drug Delivery Systems 91制片厂.
Key manufacturers engaged in the Sustained Release Drug Delivery Systems industry include West Pharmaceutical Services, Cirtec Medical, Balda, Lubrizol, Beckman Coulter, Scios, Noven Pharmaceuticals, Raritan Pharmaceuticals and Parker Hannifin, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sustained Release Drug Delivery Systems were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sustained Release Drug Delivery Systems market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sustained Release Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
West Pharmaceutical Services
Cirtec Medical
Balda
Lubrizol
Beckman Coulter
Scios
Noven Pharmaceuticals
Raritan Pharmaceuticals
Parker Hannifin
Nitto Avecia Pharma Services
KV Pharmaceutical
Equashield
Shire Laboratories
Powder Systems
B. Braun OEM Division
Pharmaco-Kinesis
Foresee
Bayer
Catalent
Pfizer
Segment by Type
Nonbiodegradable Implants
Biodegradable Implants
Micro- and Nano-Particles
Liposomes
ECT
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sustained Release Drug Delivery Systems report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Sustained Release Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Sustained Release Drug Delivery Systems
1.2 Sustained Release Drug Delivery Systems Segment by Type
1.2.1 Global Sustained Release Drug Delivery Systems Market Value Comparison by Type (2023-2029)
1.2.2 Nonbiodegradable Implants
1.2.3 Biodegradable Implants
1.2.4 Micro- and Nano-Particles
1.2.5 Liposomes
1.2.6 ECT
1.3 Sustained Release Drug Delivery Systems Segment by Application
1.3.1 Global Sustained Release Drug Delivery Systems Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sustained Release Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Drug Delivery Systems Revenue 2018-2029
1.4.2 Global Sustained Release Drug Delivery Systems Sales 2018-2029
1.4.3 Global Sustained Release Drug Delivery Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sustained Release Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Sustained Release Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sustained Release Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sustained Release Drug Delivery Systems Average Price by Manufacturers (2018-2023)
2.4 Global Sustained Release Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sustained Release Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sustained Release Drug Delivery Systems, Product Type & Application
2.7 Sustained Release Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Sustained Release Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sustained Release Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Sustained Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sustained Release Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Sustained Release Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sustained Release Drug Delivery Systems Global Sustained Release Drug Delivery Systems Sales by Region: 2018-2029
3.2.1 Global Sustained Release Drug Delivery Systems Sales by Region: 2018-2023
3.2.2 Global Sustained Release Drug Delivery Systems Sales by Region: 2024-2029
3.3 Global Sustained Release Drug Delivery Systems Global Sustained Release Drug Delivery Systems Revenue by Region: 2018-2029
3.3.1 Global Sustained Release Drug Delivery Systems Revenue by Region: 2018-2023
3.3.2 Global Sustained Release Drug Delivery Systems Revenue by Region: 2024-2029
3.4 North America Sustained Release Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Sustained Release Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sustained Release Drug Delivery Systems Sales by Country (2018-2029)
3.4.3 North America Sustained Release Drug Delivery Systems Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sustained Release Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Sustained Release Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sustained Release Drug Delivery Systems Sales by Country (2018-2029)
3.5.3 Europe Sustained Release Drug Delivery Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sustained Release Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Sustained Release Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sustained Release Drug Delivery Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Sustained Release Drug Delivery Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sustained Release Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Sustained Release Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sustained Release Drug Delivery Systems Sales by Country (2018-2029)
3.7.3 Latin America Sustained Release Drug Delivery Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sustained Release Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Sustained Release Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sustained Release Drug Delivery Systems Sales by Type (2018-2029)
4.1.1 Global Sustained Release Drug Delivery Systems Sales by Type (2018-2023)
4.1.2 Global Sustained Release Drug Delivery Systems Sales by Type (2024-2029)
4.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2018-2029)
4.2 Global Sustained Release Drug Delivery Systems Revenue by Type (2018-2029)
4.2.1 Global Sustained Release Drug Delivery Systems Revenue by Type (2018-2023)
4.2.2 Global Sustained Release Drug Delivery Systems Revenue by Type (2024-2029)
4.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2018-2029)
4.3 Global Sustained Release Drug Delivery Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sustained Release Drug Delivery Systems Sales by Application (2018-2029)
5.1.1 Global Sustained Release Drug Delivery Systems Sales by Application (2018-2023)
5.1.2 Global Sustained Release Drug Delivery Systems Sales by Application (2024-2029)
5.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2018-2029)
5.2 Global Sustained Release Drug Delivery Systems Revenue by Application (2018-2029)
5.2.1 Global Sustained Release Drug Delivery Systems Revenue by Application (2018-2023)
5.2.2 Global Sustained Release Drug Delivery Systems Revenue by Application (2024-2029)
5.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2018-2029)
5.3 Global Sustained Release Drug Delivery Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Corporation Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 West Pharmaceutical Services Sustained Release Drug Delivery Systems Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Cirtec Medical
6.2.1 Cirtec Medical Corporation Information
6.2.2 Cirtec Medical Description and Business Overview
6.2.3 Cirtec Medical Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cirtec Medical Sustained Release Drug Delivery Systems Product Portfolio
6.2.5 Cirtec Medical Recent Developments/Updates
6.3 Balda
6.3.1 Balda Corporation Information
6.3.2 Balda Description and Business Overview
6.3.3 Balda Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Balda Sustained Release Drug Delivery Systems Product Portfolio
6.3.5 Balda Recent Developments/Updates
6.4 Lubrizol
6.4.1 Lubrizol Corporation Information
6.4.2 Lubrizol Description and Business Overview
6.4.3 Lubrizol Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lubrizol Sustained Release Drug Delivery Systems Product Portfolio
6.4.5 Lubrizol Recent Developments/Updates
6.5 Beckman Coulter
6.5.1 Beckman Coulter Corporation Information
6.5.2 Beckman Coulter Description and Business Overview
6.5.3 Beckman Coulter Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beckman Coulter Sustained Release Drug Delivery Systems Product Portfolio
6.5.5 Beckman Coulter Recent Developments/Updates
6.6 Scios
6.6.1 Scios Corporation Information
6.6.2 Scios Description and Business Overview
6.6.3 Scios Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Scios Sustained Release Drug Delivery Systems Product Portfolio
6.6.5 Scios Recent Developments/Updates
6.7 Noven Pharmaceuticals
6.6.1 Noven Pharmaceuticals Corporation Information
6.6.2 Noven Pharmaceuticals Description and Business Overview
6.6.3 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product Portfolio
6.7.5 Noven Pharmaceuticals Recent Developments/Updates
6.8 Raritan Pharmaceuticals
6.8.1 Raritan Pharmaceuticals Corporation Information
6.8.2 Raritan Pharmaceuticals Description and Business Overview
6.8.3 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product Portfolio
6.8.5 Raritan Pharmaceuticals Recent Developments/Updates
6.9 Parker Hannifin
6.9.1 Parker Hannifin Corporation Information
6.9.2 Parker Hannifin Description and Business Overview
6.9.3 Parker Hannifin Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Parker Hannifin Sustained Release Drug Delivery Systems Product Portfolio
6.9.5 Parker Hannifin Recent Developments/Updates
6.10 Nitto Avecia Pharma Services
6.10.1 Nitto Avecia Pharma Services Corporation Information
6.10.2 Nitto Avecia Pharma Services Description and Business Overview
6.10.3 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product Portfolio
6.10.5 Nitto Avecia Pharma Services Recent Developments/Updates
6.11 KV Pharmaceutical
6.11.1 KV Pharmaceutical Corporation Information
6.11.2 KV Pharmaceutical Sustained Release Drug Delivery Systems Description and Business Overview
6.11.3 KV Pharmaceutical Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.11.4 KV Pharmaceutical Sustained Release Drug Delivery Systems Product Portfolio
6.11.5 KV Pharmaceutical Recent Developments/Updates
6.12 Equashield
6.12.1 Equashield Corporation Information
6.12.2 Equashield Sustained Release Drug Delivery Systems Description and Business Overview
6.12.3 Equashield Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Equashield Sustained Release Drug Delivery Systems Product Portfolio
6.12.5 Equashield Recent Developments/Updates
6.13 Shire Laboratories
6.13.1 Shire Laboratories Corporation Information
6.13.2 Shire Laboratories Sustained Release Drug Delivery Systems Description and Business Overview
6.13.3 Shire Laboratories Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shire Laboratories Sustained Release Drug Delivery Systems Product Portfolio
6.13.5 Shire Laboratories Recent Developments/Updates
6.14 Powder Systems
6.14.1 Powder Systems Corporation Information
6.14.2 Powder Systems Sustained Release Drug Delivery Systems Description and Business Overview
6.14.3 Powder Systems Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Powder Systems Sustained Release Drug Delivery Systems Product Portfolio
6.14.5 Powder Systems Recent Developments/Updates
6.15 B. Braun OEM Division
6.15.1 B. Braun OEM Division Corporation Information
6.15.2 B. Braun OEM Division Sustained Release Drug Delivery Systems Description and Business Overview
6.15.3 B. Braun OEM Division Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.15.4 B. Braun OEM Division Sustained Release Drug Delivery Systems Product Portfolio
6.15.5 B. Braun OEM Division Recent Developments/Updates
6.16 Pharmaco-Kinesis
6.16.1 Pharmaco-Kinesis Corporation Information
6.16.2 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Description and Business Overview
6.16.3 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product Portfolio
6.16.5 Pharmaco-Kinesis Recent Developments/Updates
6.17 Foresee
6.17.1 Foresee Corporation Information
6.17.2 Foresee Sustained Release Drug Delivery Systems Description and Business Overview
6.17.3 Foresee Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Foresee Sustained Release Drug Delivery Systems Product Portfolio
6.17.5 Foresee Recent Developments/Updates
6.18 Bayer
6.18.1 Bayer Corporation Information
6.18.2 Bayer Sustained Release Drug Delivery Systems Description and Business Overview
6.18.3 Bayer Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Bayer Sustained Release Drug Delivery Systems Product Portfolio
6.18.5 Bayer Recent Developments/Updates
6.19 Catalent
6.19.1 Catalent Corporation Information
6.19.2 Catalent Sustained Release Drug Delivery Systems Description and Business Overview
6.19.3 Catalent Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Catalent Sustained Release Drug Delivery Systems Product Portfolio
6.19.5 Catalent Recent Developments/Updates
6.20 Pfizer
6.20.1 Pfizer Corporation Information
6.20.2 Pfizer Sustained Release Drug Delivery Systems Description and Business Overview
6.20.3 Pfizer Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Pfizer Sustained Release Drug Delivery Systems Product Portfolio
6.20.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sustained Release Drug Delivery Systems Industry Chain Analysis
7.2 Sustained Release Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sustained Release Drug Delivery Systems Production Mode & Process
7.4 Sustained Release Drug Delivery Systems Sales and Marketing
7.4.1 Sustained Release Drug Delivery Systems Sales Channels
7.4.2 Sustained Release Drug Delivery Systems Distributors
7.5 Sustained Release Drug Delivery Systems Customers
8 Sustained Release Drug Delivery Systems Market Dynamics
8.1 Sustained Release Drug Delivery Systems Industry Trends
8.2 Sustained Release Drug Delivery Systems Market Drivers
8.3 Sustained Release Drug Delivery Systems Market Challenges
8.4 Sustained Release Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

West Pharmaceutical Services
Cirtec Medical
Balda
Lubrizol
Beckman Coulter
Scios
Noven Pharmaceuticals
Raritan Pharmaceuticals
Parker Hannifin
Nitto Avecia Pharma Services
KV Pharmaceutical
Equashield
Shire Laboratories
Powder Systems
B. Braun OEM Division
Pharmaco-Kinesis
Foresee
Bayer
Catalent
Pfizer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.